Understand the debate around asymptomatic hyperuricemia. Learn the clinical guidelines for treatment, subclinical crystal deposition, and chronic renal risks.
標籤彙整: allopurinol
Gouty Nephropathy and Uric Acid Kidney Stones: Protecting Renal Function
Learn the renal complications of hyperuricemia, including chronic gouty nephropathy, acute obstruction, and uric acid stones, and how to protect kidney function.
Allopurinol: First-Line Urate-Lowering Therapy (ULT) and Titration Targets
Discover why allopurinol is the preferred first-line treatment for chronic gout. Learn the clinical rationale for gradual titration and targeted urate lowering.
Allopurinol Hypersensitivity Syndrome (AHS): HLA-B*5801 Testing and Severe Rashes
Learn about the clinical features of Allopurinol Hypersensitivity Syndrome (AHS) and the importance of HLA-B*5801 genetic screening before starting therapy.
ULT Adherence: Overcoming the Paradox of Flare-ups During Early Therapy
Discover why medication adherence is low in gout patients and explore practical strategies to navigate the early flare-up paradox and improve outcomes.
Uric Acid and Heart Disease: Is Hyperuricemia an Independent Risk Factor?
Review the clinical evidence, vascular mechanisms, and debate surrounding hyperuricemia as an independent risk factor for cardiovascular disease.
Co-Managing Gout and Chronic Kidney Disease (CKD): Dosing Adjustments
A clinical guide to adjusting allopurinol and flare medications safely in patients with concurrent gout and chronic kidney disease.